These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 19263753

  • 1. Accuracy of tobramycin levels obtained from central venous access devices in patients with cystic fibrosis is technique dependent.
    Mogayzel PJ, Pierce E, Mills J, McNeil A, Loehr K, Joplin R, McMahan S, Carson KA.
    Pediatr Nurs; 2008; 34(6):464-8; quiz 468-9. PubMed ID: 19263753
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic sampling from central venous catheters versus peripheral veins.
    McBeth CL, McDonald RJ, Hodge MB.
    Pediatr Nurs; 2004; 30(3):200-2. PubMed ID: 15311643
    [Abstract] [Full Text] [Related]

  • 3. Comparison of central venous catheter and peripheral vein samples of antibiotics in children with cystic fibrosis.
    Wilson K, Jamerson PA.
    J Spec Pediatr Nurs; 2013 Jan; 18(1):33-41. PubMed ID: 23289453
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P, Fehling M, Bauernfeind A, Reinhardt D, Kappler M, Griese M.
    J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
    [Abstract] [Full Text] [Related]

  • 5. A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosis.
    Sherwood SJ, Tak C, Bhakta ZN, Packer K, Jacobs H, Liou TG, Young DC.
    Pediatr Pulmonol; 2024 Jun; 59(6):1740-1746. PubMed ID: 38501330
    [Abstract] [Full Text] [Related]

  • 6. Clinical report: erroneous tobramycin sampling in home intravenous therapy avoidable with modified blood draw.
    Fagerman KE.
    J Intraven Nurs; 1994 Jun; 17(3):135-7. PubMed ID: 8064498
    [No Abstract] [Full Text] [Related]

  • 7. Therapeutic antibiotic serum concentrations by two blood collection methods within the pediatric patient: A comparative effectiveness trial.
    Lichliter RL, Tremewan LE, Shonka NM, Mehnert JE, Brennan L, Thrasher JM, Hernandez TL.
    J Spec Pediatr Nurs; 2018 Apr; 23(2):e12212. PubMed ID: 29461683
    [Abstract] [Full Text] [Related]

  • 8. Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis.
    Rosenfeld M, Gibson R, McNamara S, Emerson J, McCoyd KS, Shell R, Borowitz D, Konstan MW, Retsch-Bogart G, Wilmott RW, Burns JL, Vicini P, Montgomery AB, Ramsey B.
    J Pediatr; 2001 Oct; 139(4):572-7. PubMed ID: 11598606
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sites of implantation for central venous access devices (ports): a study of the experiences and preferences of patients.
    Campbell WB, Elworthy S, Peerlinck I, Vanslembroek K, Bangur R, Stableforth D, Sheldon CD.
    Eur J Vasc Endovasc Surg; 2004 Dec; 28(6):642-4. PubMed ID: 15531201
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations.
    Coulthard KP, Peckham DG, Conway SP, Smith CA, Bell J, Turnidge J.
    J Cyst Fibros; 2007 Apr; 6(2):125-30. PubMed ID: 16829216
    [Abstract] [Full Text] [Related]

  • 12. Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis.
    Madsen V, Lind A, Rasmussen M, Coulthard K.
    J Cyst Fibros; 2004 Dec; 3(4):249-51. PubMed ID: 15698943
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Examining the push-pull method of blood sampling from central venous access devices.
    Adlard K.
    J Pediatr Oncol Nurs; 2008 Dec; 25(4):200-7. PubMed ID: 18539911
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discard volumes necessary for clinically useful coagulation studies from heparinized Hickman catheters.
    Mayo DJ, Dimond EP, Kramer W, Horne MK.
    Oncol Nurs Forum; 1996 May; 23(4):671-5. PubMed ID: 8735325
    [Abstract] [Full Text] [Related]

  • 17. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C, Bosomworth M, Clifton I, Peckham DG, Conway SP.
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [Abstract] [Full Text] [Related]

  • 18. Serum tobramycin levels following delivery of tobramycin (Tobi) via eFlow advanced nebuliser in children with cystic fibrosis.
    Guy EL, Bosomworth M, Denton M, Conway SP, Brownlee KG, Lee TW.
    J Cyst Fibros; 2010 Jul; 9(4):292-5. PubMed ID: 20427245
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Obtaining blood samples for coagulation studies from a normal saline lock.
    Powers JM.
    Am J Crit Care; 1999 Jul; 8(4):250-3. PubMed ID: 10392225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.